- Home
- GLSI vs ESOA Comparison
GLSI vs ESOA Comparison
Compare GLSI & ESOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLSI
- ESOA
- Stock Information
- Founded
- GLSI 2006
- ESOA 2006
- Country
- GLSI United States
- ESOA United States
- Employees
- GLSI N/A
- ESOA N/A
- Industry
- GLSI Biotechnology: Pharmaceutical Preparations
- ESOA Water Sewer Pipeline Comm & Power Line Construction
- Sector
- GLSI Health Care
- ESOA Industrials
- Exchange
- GLSI Nasdaq
- ESOA Nasdaq
- Market Cap
- GLSI 134.6M
- ESOA 155.3M
- IPO Year
- GLSI 2020
- ESOA 2006
- Fundamental
- Price
- GLSI $11.65
- ESOA $10.39
- Analyst Decision
- GLSI Strong Buy
- ESOA Strong Buy
- Analyst Count
- GLSI 1
- ESOA 1
- Target Price
- GLSI $39.00
- ESOA $21.00
- AVG Volume (30 Days)
- GLSI 45.8K
- ESOA 203.5K
- Earning Date
- GLSI 08-14-2025
- ESOA 08-11-2025
- Dividend Yield
- GLSI N/A
- ESOA 1.20%
- EPS Growth
- GLSI N/A
- ESOA N/A
- EPS
- GLSI N/A
- ESOA 0.17
- Revenue
- GLSI N/A
- ESOA $385,589,109.00
- Revenue This Year
- GLSI N/A
- ESOA $8.96
- Revenue Next Year
- GLSI N/A
- ESOA $7.45
- P/E Ratio
- GLSI N/A
- ESOA $59.61
- Revenue Growth
- GLSI N/A
- ESOA 9.52
- 52 Week Low
- GLSI $8.06
- ESOA $7.64
- 52 Week High
- GLSI $16.50
- ESOA $19.83
- Technical
- Relative Strength Index (RSI)
- GLSI 53.04
- ESOA 54.38
- Support Level
- GLSI $11.51
- ESOA $9.24
- Resistance Level
- GLSI $12.07
- ESOA $10.67
- Average True Range (ATR)
- GLSI 0.58
- ESOA 0.64
- MACD
- GLSI -0.07
- ESOA 0.07
- Stochastic Oscillator
- GLSI 31.86
- ESOA 88.56
About GLSI Greenwich LifeSciences Inc.
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.
About ESOA Energy Services of America Corporation
Energy Services of America Corporation is engaged in providing contracting services for energy-related companies. The company is predominantly engaged in the construction, replacement, and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It services the gas, petroleum, power, chemical, and automotive industries and does incidental work such as water and sewer projects. Energy Service's other services include liquid pipeline construction, pump station construction, production facility construction, water and sewer pipeline installations, various maintenance and repair services, and other services related to pipeline construction.